Comparison of Corneal Safety and Intraocular Pressure–Lowering Effect of Tafluprost Ophthalmic Solution with Other Prostaglandin Ophthalmic Solutions-Reference-Cited by-同舟云学术

Comparison of Corneal Safety and Intraocular Pressure–Lowering Effect of Tafluprost Ophthalmic Solution with Other Prostaglandin Ophthalmic Solutions

Published:2014-05 Issue:4 Volume:30 Page:340-345
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Kumagami Takeshi¹,Wakiyama Harumi²,Kusano Mao¹,Kajiyama Ayano¹,Miura Yoko¹,Uematsu Masafumi¹,Yoneda Ai²,Kurihara Junko²,Suzuma Kiyoshi¹,Kitaoka Takashi¹

Affiliation:

1. Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

2. Department of Ophthalmology, The Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2013.0132

Reference22 articles.

1. Preservative cytotoxicity to cultured corneal epithelial cells

2. Influence of Alkyl Chain Length of Benzalkonium Chloride on Acute Corneal Epithelial Toxicity

3. Acute Corneal Epithelial Change after Instillation of Benzalkonium Chloride Evaluated Using a Newly Developed in vivo Corneal Transepithelial Electric Resistance Measurement Method

4. Investigation of Protective Effects of Sodium Hyaluronate Eyedrop Against Corneal Epithelial Disorders Using an Electrophysiological Method

5. Optimization of Benzalkonium Chloride Concentration in 0.0015% Tafluprost Ophthalmic Solution from the Points of Ocular Surface Safety and Preservative Efficacy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of preserved Tafluprost 0.0015% in lowering intraocular pressure;Indian Journal of Ophthalmology;2023-11-20

2. Real-World Efficacy and Safety of Tafluprost in Primary Open-Angle Glaucoma Patients with Corneal Disorders: A Taiwan Experience;Journal of Ophthalmology;2022-10-29

3. Topical glaucoma medications – Clinical implications for the ocular surface;The Ocular Surface;2022-10

4. A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension;Expert Opinion on Drug Safety;2021-10-29

5. Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride;Clinical & Experimental Ophthalmology;2018-06-26